JP2010511631A5 - - Google Patents

Download PDF

Info

Publication number
JP2010511631A5
JP2010511631A5 JP2009539526A JP2009539526A JP2010511631A5 JP 2010511631 A5 JP2010511631 A5 JP 2010511631A5 JP 2009539526 A JP2009539526 A JP 2009539526A JP 2009539526 A JP2009539526 A JP 2009539526A JP 2010511631 A5 JP2010511631 A5 JP 2010511631A5
Authority
JP
Japan
Prior art keywords
oxo
methyl
hydrazino
ylidene
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009539526A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010511631A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/086186 external-priority patent/WO2008070583A2/en
Publication of JP2010511631A publication Critical patent/JP2010511631A/ja
Publication of JP2010511631A5 publication Critical patent/JP2010511631A5/ja
Pending legal-status Critical Current

Links

JP2009539526A 2006-12-01 2007-11-30 トロンボポエチン擬態物 Pending JP2010511631A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86196306P 2006-12-01 2006-12-01
PCT/US2007/086186 WO2008070583A2 (en) 2006-12-01 2007-11-30 Thrombopoietin mimetics

Publications (2)

Publication Number Publication Date
JP2010511631A JP2010511631A (ja) 2010-04-15
JP2010511631A5 true JP2010511631A5 (cg-RX-API-DMAC7.html) 2011-01-27

Family

ID=39493014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009539526A Pending JP2010511631A (ja) 2006-12-01 2007-11-30 トロンボポエチン擬態物

Country Status (6)

Country Link
US (2) US7786159B2 (cg-RX-API-DMAC7.html)
EP (1) EP2086551A4 (cg-RX-API-DMAC7.html)
JP (1) JP2010511631A (cg-RX-API-DMAC7.html)
AU (1) AU2007329464A1 (cg-RX-API-DMAC7.html)
CA (1) CA2670345A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008070583A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY2010012I2 (el) * 2000-05-25 2020-05-29 Novartis Ag Μιμητικα θρομβοποιητινης
CA2670345A1 (en) 2006-12-01 2008-06-12 Stategics, Inc. Thrombopoietin mimetics
US8476249B2 (en) 2009-05-07 2013-07-02 Glaxosmithkline Llc Method of treating thrombocytopenia
JP2012526137A (ja) * 2009-05-07 2012-10-25 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 血小板減少症を治療する方法
CN101921232A (zh) * 2009-06-11 2010-12-22 上海恒瑞医药有限公司 双环取代吡唑酮偶氮类衍生物的盐,其制备方法及其在医药上的应用
WO2012121958A2 (en) * 2011-03-08 2012-09-13 Glaxosmithkline Llc Combination
WO2013072921A2 (en) * 2011-09-13 2013-05-23 Glenmark Generics Limited Process for preparation of substituted 3'-hydrazino-biphenyl-3-carboxylic acid compounds
CN109293551A (zh) * 2011-11-14 2019-02-01 利亘制药公司 与粒细胞集落刺激因子受体相关的方法和组合物
JP6150374B2 (ja) * 2012-11-15 2017-06-21 国立大学法人弘前大学 放射線被ばく治療剤及び放射線被ばく治療方法
WO2014150252A1 (en) 2013-03-15 2014-09-25 Ligand Pharmaceuticals Incorporated Methods of treatment associated with the granulocyte colony-stimulating factor receptor
CN104257928A (zh) * 2014-10-20 2015-01-07 王艳萍 一种治疗软组织损伤疼痛综合症的中药制剂
BR112020001367A2 (pt) 2017-07-26 2020-08-11 Janssen Pharmaceutica N.V. métodos de proteção da integridade vascular induzida por terapia de radiação direcionada
MA54820A (fr) * 2019-01-25 2021-12-01 Janssen Pharmaceutica Nv Méthodes d'atténuation d'une lésion hépatique et de promotion d'une hypertrophie hépatique, de régénération du foie et de prise de greffe de cellules hépatiques conjointement avec des traitements par radiothérapie et/ou radiomimétiques
WO2024249284A2 (en) * 2023-05-26 2024-12-05 Ipsen Pharma S.A.S. Bax activators and use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE634840A (cg-RX-API-DMAC7.html) * 1961-08-10
US3141772A (en) * 1963-08-09 1964-07-21 Polaroid Corp Photographic products, processes and compositions employing azo dye developers
DE1182432B (de) * 1962-04-26 1964-11-26 Basf Ag Verfahren zur Herstellung von thermoplastischen farbigen makromolekularen Stoffen
US3666746A (en) * 1969-06-25 1972-05-30 Gaf Corp Pyrrolidonylphenyl azo dyestuffs
US5132189A (en) * 1989-09-07 1992-07-21 Fuji Electric Co., Ltd. Photoconductor for electrophotography
JPH04128767A (ja) * 1990-09-19 1992-04-30 Fuji Electric Co Ltd 電子写真用感光体
KR100423881B1 (ko) * 1999-07-29 2004-03-22 미쯔이카가쿠 가부시기가이샤 황색계 화합물을 이용한 잉크젯기록용 수계 잉크
EP1213965B1 (en) * 1999-09-10 2006-01-18 Smithkline Beecham Corporation Thrombopoietin mimetics
CY2010012I2 (el) * 2000-05-25 2020-05-29 Novartis Ag Μιμητικα θρομβοποιητινης
AU2003248630A1 (en) 2002-06-06 2003-12-22 Smithkline Beecham Corporation Thrombopoietin mimetics
WO2005118551A2 (en) 2004-05-28 2005-12-15 Ligand Pharmaceuticals Inc. Thrombopoietin activity modulating compounds and methods
US7314887B2 (en) * 2004-10-25 2008-01-01 Ligand Pharmaceuticals, Inc. Thrombopoietin activity modulating compounds and methods
US7226575B2 (en) * 2004-11-30 2007-06-05 Chevron U.S.A. Inc. Boron-containing molecular sieve CHA
CA2630234A1 (en) * 2005-11-23 2007-05-31 Ligand Pharmaceuticals Inc. Thrombopoietin activity modulating compounds and methods
BRPI0621027A2 (pt) 2006-01-13 2011-11-29 Pharmacyclics Inc composto, composição farmacêutica
CA2670345A1 (en) * 2006-12-01 2008-06-12 Stategics, Inc. Thrombopoietin mimetics

Similar Documents

Publication Publication Date Title
JP2010511631A5 (cg-RX-API-DMAC7.html)
JP2012533546A5 (cg-RX-API-DMAC7.html)
JP2010536766A5 (cg-RX-API-DMAC7.html)
JP2012502037A5 (cg-RX-API-DMAC7.html)
JP2011524850A5 (cg-RX-API-DMAC7.html)
JP2011529054A5 (cg-RX-API-DMAC7.html)
JP2010513478A5 (cg-RX-API-DMAC7.html)
CO6612204A2 (es) Nuevas composiciones de 1-(2(2.4 dimetil-fenilsulfanil)- fenil) piperazina
JP2010521514A5 (cg-RX-API-DMAC7.html)
JP2010077141A5 (cg-RX-API-DMAC7.html)
JP2007508360A5 (cg-RX-API-DMAC7.html)
JP2009538276A5 (cg-RX-API-DMAC7.html)
JP2010265321A5 (cg-RX-API-DMAC7.html)
JP2007302683A5 (cg-RX-API-DMAC7.html)
JP2010526840A5 (cg-RX-API-DMAC7.html)
JP2010507641A5 (cg-RX-API-DMAC7.html)
JP2012507535A5 (cg-RX-API-DMAC7.html)
JP2006501306A5 (cg-RX-API-DMAC7.html)
NO20082498L (no) Diarylurea for behandling av pulmonar hypertensjon
CY1112911T1 (el) Θεραπευτικος παραγοντας ηπατικης νοσου, που περιεχει παραγωγο 2-αμινο-1,3-προπανοδιολης ως δραστικο συστατικο
ES2546847T3 (es) Formulaciones de un inhibidor de la Src/Abl
JP2007502265A5 (cg-RX-API-DMAC7.html)
JP2008534558A5 (cg-RX-API-DMAC7.html)
JP2012501334A5 (cg-RX-API-DMAC7.html)
JP2010500284A5 (cg-RX-API-DMAC7.html)